Abstract:We conducted functional screening for new miRNAs that can regulate the cellular response to hypoxia by determining the effect of each miRNA on the hypoxia-inducible factor-1 alpha (HIF-1α) expression after hypoxia exposure, using a miRNA mimic pool consisting of 267 species. Among the several HIF-1α-regulating miRNA candidates identified from the functional screening, miR-5586-5p was here characterized as a potent miRNA suppressing hypoxia-induced angiogenesis in breast cancer. The expression of the critical proangiogenic factors vascular endothelial growth factor A (VEGFA) and angiopoietin-like protein 4 (ANGPTL4) were inhibited by miR-5586-5p in breast cancer cells MDA-MB-231 and BT-549. Migration and tube formation of human umbilical vein endothelial cells (HUVEC) were reduced in the conditioned medium (CM) prepared from miR-5586-5p-transfected cells compared to those in the CM prepared from control cells. In addition to HIF-1α, miR-5586-5p also suppressed the expression of heparin-binding EGF-like growth factor (HBEGF) and a disintegrin and metalloprotease 17 (ADAM17), which are known to play a role in hypoxic signaling to induce the expressions of VEGFA and ANGPTL4. HIF-1α, HBEGF, and ADAM17 were verified as the direct targets of miR-5586-5p. Forced downregulation of HIF-1α, HBEGF, or ADAM17 phenocopied the angiogenesis-suppressing function of miR-5586-5p, while the ectopic expression of HIF-1α or HBEGF suppressed the function of miR-5586-5p. Expression levels of miR-5586-5p were lower in tumor tissues than in neighboring normal tissues of breast cancer patients. Inverse correlations of miR-5586-5p expression to those of HIF-1α, HBEGF, ADAM17, VEGFA, and ANGPTL4 were demonstrated both in tumor tissues and by using miR-5586-5p-monitoring reporter cells. In vivo study using orthotopic MDA-MB-231 xenografts in mice revealed that angiogenesis and subsequent tumor growth were suppressed by intratumoral injection of miR-5586-5p mimic. Taken together, our results suggest a novel tumor-suppressive function of miR-5586-5p and its promising applicability for the development of a novel cancer treatment strategy. Graphical abstract Download: Download high-res image (135KB) Download: Download full-size image

Global Microrna Depletion Suppresses Tumor Angiogenesis.

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

MicroRNAs in tumor angiogenesis

Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis.

MicroRNAs and Tumor Angiogenesis

miR-5586-5p suppresses hypoxia-induced angiogenesis through multiple targeting of HIF-1α, HBEGF, and ADAM17 in breast cancer

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability

MicroRNA-503 Targets FGF2 and VEGFA and Inhibits Tumor Angiogenesis and Growth.

Tumor-Derived Microrna-494 Promotes Angiogenesis in Non-Small Cell Lung Cancer

MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia

A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.

HIF1α Counteracts TGFβ1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment

MicroRNA‐185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1

Microrna-195 Suppresses Angiogenesis and Metastasis of Hepatocellular Carcinoma by Inhibiting the Expression of Vegf, Vav2, and Cdc42

MiR-145 Directly Targets P70s6k1 in Cancer Cells to Inhibit Tumor Growth and Angiogenesis.

MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs

Abstract 3980: Hypoxia-induced Microrna-424 Targets CUL2 to Stabilize HIF-α Isoforms and Promotes Angiogenesis

Microrna-320B Suppresses HNF4G and IGF2BP2 Expression to Inhibit Angiogenesis and Tumor Growth of Lung Cancer.

MicroRNA 329 suppresses angiogenesis by targeting CD146.

Hypoxia-induced Deregulation of Mir-126 and Its Regulative Effect on VEGF and MMP-9 Expression.